Intelligent Investor

G Medical Innovations Holdings Limited (ASX: GMV) - Announcements

DELISTED - Current share price for GMV : $0.039

ASX company news and announcements for G Medical Innovations Holdings Limited (GMV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All G Medical Innovations Holdings Limited (GMV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than G Medical Innovations Holdings Limited (GMV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for G Medical Innovations Holdings Limited (GMV)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Issued Units Outstanding as at 30 April 2024 6 May 2024 5:21PM $0.039 $0.039 $0.039 fallen by 0%
- Monthly Disclosure Information as at 30 April 2024 6 May 2024 11:16AM $0.039 $0.039 $0.039 fallen by 0%
- Units Outstanding & Other Information as at 31 March 2024 3 Apr 2024 8:27AM $0.039 $0.039 $0.039 fallen by 0%
- Units Outstanding & Other Information as at 29 Feb 2024 7 Mar 2024 4:38PM $0.039 $0.039 $0.039 fallen by 0%
- Indicative dividends calendar for 2024 5 Mar 2024 6:07PM $0.039 $0.039 $0.039 fallen by 0%
- Product Disclosure Statement 29 Feb 2024 8:59AM $0.039 $0.039 $0.039 fallen by 0%
- Admission and Commencement of Trading - GMVW 29 Feb 2024 8:08AM $0.039 $0.039 $0.039 fallen by 0%
- Removal from Official List of ASX 23 Oct 2020 3:08PM $0.039 $0.039 $0.039 fallen by 0%
- G Medical Files Registration Statement with US SEC 2 Oct 2020 10:43AM $0.039 $0.039 $0.039 fallen by 0%
- Appendix 2A 30 Sep 2020 3:49PM $0.039 $0.039 $0.039 fallen by 0%
- Notice of Extraordinary General Meeting 29 Sep 2020 3:32PM $0.039 $0.039 $0.039 fallen by 0%
- Suspension from Official Quotation 21 Sep 2020 5:24PM $0.039 $0.039 $0.039 fallen by 0%
- Results of Meeting 21 Sep 2020 4:53PM $0.039 $0.039 $0.039 fallen by 0%
- General Meeting Dial-In Details 14 Sep 2020 4:00PM $0.033 $0.039 $0.039 risen by 18.18%
- ASX Confirms G Medical Delisting 1 Sep 2020 3:44PM $0.041 $0.039 $0.039 fallen by 4.88%
- Half Year Accounts 1 Sep 2020 8:07AM $0.041 $0.039 $0.039 fallen by 4.88%
- New revenue stream added to IDTF platform 27 Aug 2020 9:48AM $0.042 $0.039 $0.039 fallen by 7.14%
- Ten US university hospitals now deploying IDTF platform 24 Aug 2020 9:08AM $0.041 $0.039 $0.039 fallen by 4.88%
- Notice of Extraordinary General Meeting 21 Aug 2020 5:54PM $0.041 $0.039 $0.039 fallen by 4.88%
- Additional information on Nasdaq listing 20 Aug 2020 9:29AM $0.040 $0.039 $0.039 fallen by 2.50%
- Becoming a substantial holder 17 Aug 2020 4:53PM $0.042 $0.039 $0.039 fallen by 7.14%
- Change of Director's Interest Notice X 2 14 Aug 2020 4:16PM $0.043 $0.039 $0.039 fallen by 9.30%
- Prospectus 13 Aug 2020 7:08PM $0.051 $0.039 $0.039 fallen by 23.53%
- Appendix 2A 13 Aug 2020 6:56PM $0.051 $0.039 $0.039 fallen by 23.53%
- Appendix 3G 13 Aug 2020 6:51PM $0.051 $0.039 $0.039 fallen by 23.53%

1 - 25 of 328 results

Page 1 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.